Biogen tops estimates, raises profit guidance as Alzheimer’s drug Leqembi gains traction
Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company’s multiple sclerosis products.
Similar Posts
Ambani and Adani drop out of $100 billion club
Mukesh Ambani and Gautam Adani, once centibillionaires, have seen their fortunes decline. Ambani’s Reliance conglomerate faces underperforming energy and retail businesses, while Adani confronts a US Department of Justice probe over alleged bribery, adding to the fallout from previous fraud accusations. Both tycoons are battling to regain investor confidence amidst these mounting challenges.
Department of Education launches ‘EndDEI’ portal for parents, students, teachers to report discrimination
The U.S. Department of Education (ED) on Thursday launched a portal allowing parents to report what’s been going on in classrooms. Parents can now go to EndDEI.gov to “describe in as much detail as possible the discriminatory practice taking place,” as well as sections to list the school district and zip code. “The U.S. Department of…
From IPL Mates to BGT Rivals: Starc lauds Gambhir’s game-changing strategies
Australian bowler Mitchell Starc praised Gautam Gambhir’s strategic thinking, crediting him for Kolkata Knight Riders’ success in the IPL. Gambhir, as KKR’s mentor, focused on team strategies and technical adjustments, leading to their championship win. Starc highlighted Gambhir’s exceptional game analysis and team-first approach.
